Does DOXORUBICIN Cause Neoplasm recurrence? 240 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 240 reports of Neoplasm recurrence have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.3% of all adverse event reports for DOXORUBICIN.
240
Reports of Neoplasm recurrence with DOXORUBICIN
0.3%
of all DOXORUBICIN reports
29
Deaths
42
Hospitalizations
How Dangerous Is Neoplasm recurrence From DOXORUBICIN?
Of the 240 reports, 29 (12.1%) resulted in death, 42 (17.5%) required hospitalization, and 40 (16.7%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 240 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
DEXAMETHASONE (135)
Which DOXORUBICIN Alternatives Have Lower Neoplasm recurrence Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE